Current News from our Company

Comprehensive SARS-CoV-2 product portfolio

In addition to our fully automatable Anti-SARS-CoV-2 ELISAs, we are pleased to complement our portfolio with the DEDIATEST 2019-nCoV-Antigen Rapid Test in cooperation with Devidia (Weimar, Germany).

\ read more

Outstanding study results

Our SERION ELISA agile SARS-CoV-2 IgG was tested in an Independent study against 7 assays from competitors.

\ read more

Now available!

Fully automatable Anti-SARS-CoV-2 ELISAs based on high quality antigens

\ read more

Now available: SERION ELISA classic Dengue Virus superior IgM

We are very happy to announce that the new SERION ELISA classic Dengue Virus superior IgM test will supplement our panel for the detection of tropical infectious diseases.

\ read more

Coming soon!

Fully automatable Anti-SARS-CoV-2 ELISAs based on high antigens

\ read more

Availability of SERION products

Concerning the global development of the Coronavirus (SARS-CoV-2), Institut Virion\Serion GmbH still assures the continuous supply of our products to our distributors and customers.

\ read more

Successful trade fair at MEDLAB Middle East in Dubai

Institut Virion\Serion GmbH experienced four successful days in Dubai.

\ read more